Sort
15,842 grants matching “pancreatic cancer”
An Inducible Model for Studying Cancer Stem Cells in PDAC
$401,117Chunling Yi · Georgetown University · R21 · FY2021 · CA
Serum-based assays for pancreatic cancer detection
$400,912Rosaura P.c. Valle · Milagen, Inc. · R44 · FY2008 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$400,902Terence Marques Williams · Ohio State University · R01 · FY2016 · CA
Development of a Novel Armored CAR-T Immunotherapeutic for Pancreatic Cancer
$400,835Gary G. Altman · Cambium Oncology Llc · R44 · FY2025 · CA
TARGETING KRAS FOR PANCREATIC CANCER TREATMENT
$400,758University Of North Carolina At Chapel Hill · · FY2015 · Department of the Army
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$400,313Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$400,246Scott Andrew Gerber · University Of Rochester · R01 · FY2021 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$400,246Scott Andrew Gerber · University Of Rochester · R01 · FY2020 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$400,151Murray Korc · Indiana University Indianapolis · R37 · FY2012 · CA
Targeting cadherin-11 in pancreatic cancer
$400,000Sivanesan Dakshanamurthy · Diviner Therapeutics, Llc · R41 · FY2022 · CA
Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer
$400,000Dung T Le · Johns Hopkins University · R01 · FY2016 · FD
Non-invasive detection of tumor NTRK gene fusions via rapid, efficient and low-cost extracellular vesicle isolation method
$400,000Hongzhang He · Captis Diagnostics · R43 · FY2023 · CA
AI-powered engineering and analysis of cyanobacterium vesicles targeting gastrointestinal cancer
$400,000Liyun Jessica Sang · Accure Health, Inc. · R43 · FY2025 · CA
Targeting pancreatic cancer metastases with Targefrin
$400,000Carlo Baggio · Armida Labs, Inc. · R43 · FY2023 · CA
Cancer Center Support Grant (CCSG)
$400,000George J Weiner · University Of Iowa · P30 · FY2016 · CA
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
$400,000Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2024 · CA
SIRPant Technology for anti-Cancer Immunity
$400,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2021 · CA
Development of a novel pan-cancer CAR-T product against AML and Glioblastoma
$400,000David Soler · Kure. Ai, Inc. · R43 · FY2024 · CA
An Aptamer-directed IgG1-Fc Drug Conjugate (AFDC) for Treating Pancreatic Cancer
$400,000Xiang Gao · Oncotrap, Inc. · R43 · FY2023 · CA
Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer
$400,000Dung T Le · Johns Hopkins University · R01 · FY2014 · FD
An integrated strategy using a serum and imaging biomarker for the early detection of pancreatic cancer.
$400,000Pinku Mukherjee · Oncotab, Inc · R41 · FY2021 · CA
Optimized targeted radiotherapy of pancreatic cancer
$400,000Pinku Mukherjee · Oncotab, Inc · R41 · FY2025 · CA
Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer
$400,000Dung T Le · Johns Hopkins University · R01 · FY2017 · FD
Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer
$400,000Dung T Le · Johns Hopkins University · R01 · FY2015 · FD
Perform non-GLP and GLP TOX/TK studies, and file a novel drug IND with the FDA for advanced pancreatic cancer patient clinical trials
$400,000Xiang Ling · Canget Biotekpharma, Llc · R43 · FY2023 · CA